Term
|
Definition
| the ability of a drug to reach its target cells and produce its effect |
|
|
Term
|
Definition
| strict chemical nomenclature used for naming drugs established by the International Union of Pure and Applied Chemistry (IUPAC) |
|
|
Term
|
Definition
| drug product with more than one active generic ingredient |
|
|
Term
|
Definition
| In the U.S., this is a drug whose use is restricted by the Comprehensive Drug Abuse Prevention and Control Act. In Canada, it is a drug subject to guidelines outlined in Part III, Schedule G of the Canadian Food and Drugs Act |
|
|
Term
|
Definition
| nonproprietary name of a drug assigned by the government |
|
|
Term
|
Definition
| how a drug exerts its effects |
|
|
Term
| pharmacological classification |
|
Definition
| method for organizing drugs ont he basis of their mechanism of action (how they work pharmacologically) |
|
|
Term
|
Definition
| an original, well-understood drug model from which other drugs in a pharmacological class have been developed |
|
|
Term
|
Definition
| In Canada, a drug not intended for human use, covered in Part IV, Schedule H of the Canadian Food and Drugs Act |
|
|
Term
|
Definition
| In the U.S., a term describing a drug placed into one of five categories (I through V) based on its potential for misuse or abuse |
|
|
Term
| therapeutic classification |
|
Definition
| method for organizing drugs on the basis of their therapeutic usefulness |
|
|
Term
|
Definition
| proprietary name of a drug assigned by the manufacturer; also called the brand name or product name |
|
|
